ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 941,64
0,88%
Dow Jones
44 944,61
0,52%
DAX
21 727,20
0,48%
Brent Oil
75,915
-0,01%
Bitcoin
105 391,21
1,59%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Virpax Pharmaceuticals Inc (VRPX) Cours

Virpax Pharmaceuticals Inc

Virpax Pharmaceuticals Inc (VRPX)

NASDAQ
0,3007
-0,0223
( -6,90% )
Mis à jour : 20:26:16
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
0,3007
Prix Achat
0,3007
Prix Vente
0,3059
Volume échangé
376 042
0,29 Fourchette du Jour 0,333
0,23 Plage de 52 semaines 5,48
Cap du marché
1,47M
Clôture Veille
0,323
Ouverture
0,3256
Dernière Transaction
222
@
0.3007
Dernière heure de transaction
20:26:16
Volume financier
US$ 112 905
VWAP
0,300245
Volume moyen (3 m)
4 159 036
Actions en circulation
4 887 581
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,09
Bénéfice par action (BPA)
-3,11
Chiffre d'affairess
-
Bénéfice net
-15,19M

À propos de Virpax Pharmaceuticals Inc

Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray. Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.virpaxpharma.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Virpax Pharmaceuticals Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker VRPX. Le dernier cours de clôture d'Virpax Pharmaceuticals était de US$0,32. Au cours de la dernière année, les actions de Virpax Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 0,23 à US$ 5,48.

Virpax Pharmaceuticals compte actuellement 4 887 581 actions en circulation. La capitalisation boursière d'Virpax Pharmaceuticals est de US$1,58 million. Virpax Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -0.09.

VRPX Dernières nouvelles

Plus de nouvelles

Virpax Pharmaceuticals, Inc. Announces Closing of $6.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a preclinical-stage pharmaceutical company focused in novel and proprietary drug delivery systems across various pain...

il y a 5 heures
Business Wire

Form 424B4 - Prospectus [Rule 424(b)(4)]

28 Janvier 2025
Edgar (US Regulatory)

Virpax Pharmaceuticals, Inc. Announces Pricing of $6 Million Public Offering of Common Stock and Pre-Funded Warrants

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a preclinical-stage pharmaceutical company focused in novel and proprietary drug delivery systems across various pain...

28 Janvier 2025
Business Wire

Form EFFECT - Notice of Effectiveness

28 Janvier 2025
Edgar (US Regulatory)

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

17 Janvier 2025
Edgar (US Regulatory)

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

15 Janvier 2025
Edgar (US Regulatory)

Form 8-K - Current report

15 Janvier 2025
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

08 Janvier 2025
Edgar (US Regulatory)

Form 8-K - Current report

07 Janvier 2025
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

06 Janvier 2025
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.01274.409722222220.2880.3470.238437140.30760686CS
4-0.0861-22.2595656670.38680.44930.235156880.34118009CS
12-0.4313-58.92076502730.7321.050.2341590360.52749181CS
26-0.9393-75.751.241.320.2319600480.55138512CS
52-2.9653-90.79301898353.2665.480.2324897981.08004459CS
156-19.8993-98.511386138620.2250.238878921.70550925CS
260-79.6993-99.62412580359.7990.23117499548.8567554CS

VRPX - Frequently Asked Questions (FAQ)

What is the current Virpax Pharmaceuticals share price?
The current share price of Virpax Pharmaceuticals is US$ 0,3007
How many Virpax Pharmaceuticals shares are in issue?
Virpax Pharmaceuticals has 4 887 581 shares in issue
What is the market cap of Virpax Pharmaceuticals?
The market capitalisation of Virpax Pharmaceuticals is USD 1,58M
What is the 1 year trading range for Virpax Pharmaceuticals share price?
Virpax Pharmaceuticals has traded in the range of US$ 0,23 to US$ 5,48 during the past year
What is the PE ratio of Virpax Pharmaceuticals?
The price to earnings ratio of Virpax Pharmaceuticals is -0,09
What is the reporting currency for Virpax Pharmaceuticals?
Virpax Pharmaceuticals reports financial results in USD
What is the latest annual profit for Virpax Pharmaceuticals?
The latest annual profit of Virpax Pharmaceuticals is USD -15,19M
What is the registered address of Virpax Pharmaceuticals?
The registered address for Virpax Pharmaceuticals is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Virpax Pharmaceuticals website address?
The website address for Virpax Pharmaceuticals is www.virpaxpharma.com
Which industry sector does Virpax Pharmaceuticals operate in?
Virpax Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
FOXXFoxx Development Holdings Inc
US$ 9,2114
(218,73%)
30,34M
AMODAlpha Modus Holdings Inc
US$ 3,22
(109,09%)
119,94M
TECXTectonic Therapeutic Inc
US$ 49,2046
(91,31%)
4,69M
ACONAclarion Inc
US$ 15,28
(65,86%)
2,63M
ATHEAlterity Therapeutics Limited
US$ 4,82
(65,64%)
21,25M
CLEUChina Liberal Education Holdings Ltd
US$ 0,191401
(-97,53%)
211,32M
CRGXCARGO Therapeutics Inc
US$ 3,4299
(-74,00%)
17,77M
EVTVEnvirotech Vehicles Inc
US$ 0,375
(-43,78%)
3,29M
IRWDIronwood Pharmaceuticals Inc
US$ 2,305
(-38,04%)
7,9M
SLXNSilexion Therapeutics Corporation
US$ 1,96
(-37,58%)
12M
NVDANVIDIA Corporation
US$ 121,265
(-1,97%)
246,4M
CLEUChina Liberal Education Holdings Ltd
US$ 0,1928
(-97,51%)
211,33M
MGOLMGO Global Inc
US$ 0,1216
(19,57%)
151,52M
AMODAlpha Modus Holdings Inc
US$ 3,2299
(109,73%)
119,94M
SPGCSacks Parente Golf Inc
US$ 0,9301
(57,64%)
115,23M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
VRPX
Virpax Pharmaceuticals
BIT
NSCIT2210002
Republic of Lithuania
BIT
S29320
Societe Generale Effekten
BIT
UC7YZ6
Unicredit Bank
BIT
UC4KSA
Unicredit Bank
BIT
1CVX
Chevron
BIT
F25250
Vontobel Financial Produ...
BIT
F39042
Vontobel Financial Produ...
BIT
F30892
Vontobel Financial Produ...
BIT
F21920
Vontobel Financial Produ...
BIT
UC8ALF
Unicredit Bank
BIT
UB7RVA
Unicredit Bank
BIT
F39595
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces